Education and professional Christer holds a BSc in business administration and economics from Örebro University. Former experience in the pharmaceutical industry includes CEO at Sedana Medical Group (publ) (2017-2021) and CEO at Unimedic Group (2010–2016), CEO at Eisai AB (2005–2010) and more than 10 years of experience in leading positions in sales and marketing at e.g. AstraZeneca (including launch of Nexium), Meda and Wyeth.

Other Board member in FrostPharma AB, Prooxpharma AB and Glycorex Transplantation AB. CEO and deputy board member in Waxholm by the sea AB.

Education and professional PhD in Cell-and Molecular Biology from Lund University. Former experience in the pharmaceutical industry includes CEO, COO and Clinical Advisor at SDS Life Science (2017-2021), Clinical- and Global Project Manager and Scientist in different positions at AstraZeneca R&D (2001 -2012). He brings almost 20 years of experience from drug development and project management.

Education and professional MD and PhD in Medical Sciences, Consultant in Internal Medicine and Hematology/Hematooncology with more than 15 years’ of Clinical experience. From 2009 full time in the Pharmaceutical Industry at different positions within Medical Affairs and Clinical Development at national, regional and global levels in Genzyme, Roche, Alexion, Alnylam and Oncopeptides.

Education and professional Ph.D. Pharmacologist with 30 years’ of experience from Astra/AstraZeneca.

Other Preclinical project leader for Losec, the first PPI (Proton Pump Inhibitor) on the market. Preclinical project leader for Nexium including clinical, marketing and regulatory support. Discovery project leader on the P-CAB (Potassium-Competitive Acid Blocker) programme bringing linaprazan through the phase II clinical studies.

Education and professional Maria holds a BSc in Business Administration and Economics from Stockholm University. She was formerly the CFO of Sedana Medical Group (2017-2021) and Managing Director at Cross Pharma AB (2015–2016). Maria has also extensive experience from leading positions within finance for the past 20 years within Medivir, Biovitrum, Bristol Myers Squibb and Ericsson.

Other Board Member in her own consultant company FAYSIT – Finance At Your Service In Tyresö AB and Advisory board member in Ugglapraktiken AB.

Education and professional Education and professional MD. Ph.D. Gastroenterologist and Internal Medicine with 25 years’ of Clinical experience.

Other Developed the first modern H. pylori eradication therapy principles. Supported sNDAs and medical affairs at AstraZeneca for 13 years. Novartis HQ in Basel, Switzerland for 12 years. Assigned as VP and Head of the Scientific Office, SOP and Training compliance Offices.